Search research articles
Contact Us
Filters
Showing results (21-30 of 56) with videos related to
Page
of 6
Sort By:
The Journal of Clinical Investigation
|
September 1, 1991
Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages
R C Hubbard, G Fells, J Gadek, et al.
Clinical Therapeutics
|
August 25, 2001
A double-blind, randomized comparison of intramuscularly and intravenously administered parecoxib sodium versus ketorolac and placebo in a post-oral surgery pain model
S E Daniels, E H Grossman, M E Kuss, et al.
Molecular and Cellular Biology
|
January 1, 1990
Molecular basis of alpha 1-antitrypsin deficiency and emphysema associated with the alpha 1-antitrypsin Mmineral springs allele
D T Curiel, C Vogelmeier, R C Hubbard, et al.
The Journal of Clinical Investigation
|
November 1, 1987
Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase
F Ogushi, G A Fells, R C Hubbard, et al.
Annals of Internal Medicine
|
August 1, 1989
Anti-neutrophil-elastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin
R C Hubbard, M L Brantly, S E Sellers, et al.
The Journal of Clinical Investigation
|
June 1, 1987
Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis
A M Cantin, S L North, G A Fells, et al.
Journal of Clinical Pharmacology
|
February 9, 2000
Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial
P T Leese, R C Hubbard, A Karim, et al.
The Journal of Rheumatology
|
December 22, 1999
Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis
A Karim, D S Tolbert, T L Hunt, et al.
Chest
|
January 1, 1989
The alpha 1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy
R G Crystal, M L Brantly, R C Hubbard, et al.
The Journal of Clinical Investigation
|
October 1, 1989
Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency
R C Hubbard, N G McElvaney, S E Sellers, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 56) with videos related to
Sort By:
Page
of 6
The Journal of Clinical Investigation
|
September 1, 1991
Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages
R C Hubbard, G Fells, J Gadek, et al.
Clinical Therapeutics
|
August 25, 2001
A double-blind, randomized comparison of intramuscularly and intravenously administered parecoxib sodium versus ketorolac and placebo in a post-oral surgery pain model
S E Daniels, E H Grossman, M E Kuss, et al.
Molecular and Cellular Biology
|
January 1, 1990
Molecular basis of alpha 1-antitrypsin deficiency and emphysema associated with the alpha 1-antitrypsin Mmineral springs allele
D T Curiel, C Vogelmeier, R C Hubbard, et al.
The Journal of Clinical Investigation
|
November 1, 1987
Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase
F Ogushi, G A Fells, R C Hubbard, et al.
Annals of Internal Medicine
|
August 1, 1989
Anti-neutrophil-elastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin
R C Hubbard, M L Brantly, S E Sellers, et al.
The Journal of Clinical Investigation
|
June 1, 1987
Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis
A M Cantin, S L North, G A Fells, et al.
Journal of Clinical Pharmacology
|
February 9, 2000
Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial
P T Leese, R C Hubbard, A Karim, et al.
The Journal of Rheumatology
|
December 22, 1999
Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis
A Karim, D S Tolbert, T L Hunt, et al.
Chest
|
January 1, 1989
The alpha 1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy
R G Crystal, M L Brantly, R C Hubbard, et al.
The Journal of Clinical Investigation
|
October 1, 1989
Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency
R C Hubbard, N G McElvaney, S E Sellers, et al.
Page
of 6